Τίτλος:
Efficacy and tolerability of once-weekly selinexor, bortezomib, and
dexamethasone in comparison with standard twice-weekly bortezomib and
dexamethasone in previously treated multiple myeloma with renal
impairment: Subgroup analysis from the BOSTON study
Συγγραφείς:
Delimpasi, Sosana
Mateos, Maria Victoria
Auner, Holger W. and
Gavriatopoulou, Maria
Dimopoulos, Meletios A.
Quach, Hang and
Pylypenko, Halyna
Hajek, Roman
Leleu, Xavier
Dolai, Tuphan
Kanti
Sinha, Dinesh Kumar
Venner, Christopher P.
Benjamin,
Reuben
Garg, Mamta Krishnan
Doronin, Vadim
Levy, Yair and
Moreau, Philippe
Chai, Yi
Arazy, Melina
Shah, Jatin and
Shacham, Sharon
Kauffman, Michael G.
Richardson, Paul G. and
Grosicki, Sebastian
